Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 2
2010 1
2011 1
2012 1
2013 1
2016 2
2018 2
2019 2
2020 1
2021 7
2022 7
2023 15
2024 13
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies.
Locke FL, Munoz JL, Tees MT, Lekakis LJ, de Vos S, Nath R, Stevens DA, Malik SA, Shouse GP, Hamadani M, Oluwole OO, Perales MA, Miklos DB, Fisher PW, Feng A, Navale L, Le Gall JB, Neelapu SS. Locke FL, et al. Among authors: shouse gp. J Clin Oncol. 2025 May 10;43(14):1695-1705. doi: 10.1200/JCO-24-01933. Epub 2025 Feb 13. J Clin Oncol. 2025. PMID: 39946666 Free PMC article. Clinical Trial.
CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma.
Xavier S, Nguyen V, Khairnar V, Phan A, Yang L, Nelson MS, Shukla RP, Wang J, Li A, Geng H, Lee J, Sadras T, Pham LV, Weisenburger DD, Chan WC, Lang KS, Shouse GP, Danilov AV, Song JY, Parekh S, Müschen M, Ngo VN. Xavier S, et al. Among authors: shouse gp. Nat Commun. 2025 May 29;16(1):4967. doi: 10.1038/s41467-025-60208-3. Nat Commun. 2025. PMID: 40436855 Free PMC article.
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
Kittai AS, Huang Y, Miller S, Allan JN, Bhat SA, Bond DA, Brander DM, Byrd JC, Chavez JC, Chong E, Davids MS, Danilov AV, Ding W, Dowling MR, Dvorak-Kornaus K, Freedman H, Hampel PJ, Ho C, Hwang SR, Islam P, Malakhov N, Matasar M, Miller C, Omer Z, Parikh SA, Parry E, Rabe KG, Raess PW, Rai M, Roeker L, Rhodes J, Rogers KA, Saha A, Schade J, Scott HW, Shadman M, Shouse G, Skarbnik A, Spurgeon S, Stephens DM, Thompson MC, Thompson PA, Wang Y, Yano M, Woyach JA. Kittai AS, et al. Among authors: shouse g. Blood Cancer J. 2025 Feb 20;15(1):23. doi: 10.1038/s41408-025-01236-6. Blood Cancer J. 2025. PMID: 39979241 Free PMC article. No abstract available.
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV, David KA, Torka P, Hashmi H, Hess B, Barta SK, Romancik JT, Cohen JB, Annunzio K, Kittai AS, Reneau J, Zurko J, Nizamuddin IA, Winter JN, Gordon LI, Ma S, Patel R, Nastoupil L, Ahmed S, Karmali R. Epperla N, et al. Among authors: shouse g. J Hematol Oncol. 2023 Nov 9;16(1):111. doi: 10.1186/s13045-023-01508-3. J Hematol Oncol. 2023. PMID: 37946255 Free PMC article.
Aberrant splicing and drug resistance in AML.
de Necochea-Campion R, Shouse GP, Zhou Q, Mirshahidi S, Chen CS. de Necochea-Campion R, et al. Among authors: shouse gp. J Hematol Oncol. 2016 Sep 10;9(1):85. doi: 10.1186/s13045-016-0315-9. J Hematol Oncol. 2016. PMID: 27613060 Free PMC article. Review.
70 results